Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: preclinical gastrointestinal and tendon repair
Also known as: BPC157, Body Protection Compound 157
BPC-157 is a synthetic 15-amino-acid peptide widely marketed for recovery. Most evidence is from cells and animals. Published human evidence includes a two-person IV safety pilot and small uncontrolled reports; a registered oral trial did not produce a public efficacy dataset. FDA's July 2026 review emphasized uncertain substance characterization, limited human safety, and inadequate evidence of effectiveness. An advisory committee vote on compounding is nonbinding and does not make BPC-157 FDA-approved.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: FDA 2026 review, published human pilot, recent translational review, WADA, and current vendors/community
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Current vendors commonly list 5 mg, 10 mg, and 20 mg lyophilized vials plus 250-500 ug capsules. BPC-157 remains unapproved. The July 23, 2026 advisory vote was not an FDA approval or final compounding rule. It is prohibited at all times for athletes under WADA S0.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention BPC-157 or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.